454 related articles for article (PubMed ID: 31405804)
1. Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health.
Lopez MI; Cocohoba J; Cohen SE; Trainor N; Levy MM; Dong BJ
J Am Pharm Assoc (2003); 2020; 60(1):138-144. PubMed ID: 31405804
[TBL] [Abstract][Full Text] [Related]
2. An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies.
Bellman R; Mohebbi S; Nobahar N; Parizher J; Apollonio DE
J Am Pharm Assoc (2003); 2022; 62(1):370-377.e3. PubMed ID: 34429253
[TBL] [Abstract][Full Text] [Related]
3. Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss!
Lopez MI; Grant RM; Dong BJ
J Am Pharm Assoc (2003); 2020; 60(4):e18-e24. PubMed ID: 32165026
[TBL] [Abstract][Full Text] [Related]
4. Attitudes about community pharmacy access to HIV prevention medications in California.
Koester KA; Saberi P; Fuller SM; Arnold EA; Steward WT
J Am Pharm Assoc (2003); 2020; 60(6):e179-e183. PubMed ID: 32665097
[TBL] [Abstract][Full Text] [Related]
5. Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men.
Crawford ND; Josma D; Morris J; Hopkins R; Young HN
J Am Pharm Assoc (2003); 2020; 60(4):602-608. PubMed ID: 32007364
[TBL] [Abstract][Full Text] [Related]
6. Implementing a collaborative practice agreement for HIV pre-exposure prophylaxis in the primary care setting.
Lee LC; Pollak BA; Coffey CP
J Am Pharm Assoc (2003); 2023; 63(1):383-388. PubMed ID: 36244883
[TBL] [Abstract][Full Text] [Related]
7. Advancing the HIV Pre-Exposure Prophylaxis Continuum: A Collaboration Between a Public Health Department and a Federally Qualified Health Center in the Southern United States.
Clement ME; Johnston BE; Eagle C; Taylor D; Rosengren AL; Goldstein BA; Seña AC
AIDS Patient Care STDS; 2019 Aug; 33(8):366-371. PubMed ID: 31233329
[TBL] [Abstract][Full Text] [Related]
8. Awareness and uptake of pre-exposure prophylaxis for HIV among low-income, HIV-negative heterosexuals in San Francisco.
Namara D; Xie H; Miller D; Veloso D; McFarland W
Int J STD AIDS; 2021 Jul; 32(8):704-709. PubMed ID: 33530898
[TBL] [Abstract][Full Text] [Related]
9. Willingness to Discuss and Screen for Pre-Exposure Prophylaxis in Pharmacies Among Men Who Have Sex With Men.
Crawford ND; Albarran T; Chamberlain A; Hopkins R; Josma D; Morris J; Onwubiko UN
J Pharm Pract; 2021 Oct; 34(5):734-740. PubMed ID: 32067554
[TBL] [Abstract][Full Text] [Related]
10. Community Levels of PrEP Use Among Men Who Have Sex with Men by Race/Ethnicity, San Francisco, 2017.
Raymond HF; Snowden JM; Guigayoma J; McFarland W; Chen YH
AIDS Behav; 2019 Oct; 23(10):2687-2693. PubMed ID: 30758787
[TBL] [Abstract][Full Text] [Related]
11. Addressing disparities in Pre-exposure Prophylaxis (PrEP) access: implementing a community-centered mobile PrEP program in South Florida.
Butts SA; Young B; Blackmon J; Doblecki-Lewis S
BMC Health Serv Res; 2023 Nov; 23(1):1311. PubMed ID: 38012701
[TBL] [Abstract][Full Text] [Related]
12. Acute HIV at the Time of Initiation of Pre-exposure or Post-exposure Prophylaxis: Impact on Drug Resistance and Clinical Outcomes.
Johnson KA; Chen MJ; Kohn R; Sachdev D; Bacon O; Lee S; Cohen SE
J Acquir Immune Defic Syndr; 2021 Jun; 87(2):818-825. PubMed ID: 33512849
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.
Tung EL; Thomas A; Eichner A; Shalit P
Sex Health; 2018 Nov; 15(6):556-561. PubMed ID: 30401342
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of users of pre-exposure prophylaxis (PrEP) among men who have sex with men, San Francisco, 2014 in a cross-sectional survey: implications for disparities.
Snowden JM; Chen YH; McFarland W; Raymond HF
Sex Transm Infect; 2017 Feb; 93(1):52-55. PubMed ID: 27356041
[TBL] [Abstract][Full Text] [Related]
15. Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California.
Hunter LA; Packel LJ; Chitle P; Beltran RM; Rafie S; De Martini L; Dong B; Harris O; Holloway IW; Miyashita Ochoa A; McCoy SI
Open Forum Infect Dis; 2023 Nov; 10(11):ofad549. PubMed ID: 38023549
[TBL] [Abstract][Full Text] [Related]
16. HIV Seroconversion in the Era of Pharmacologic Prevention: A Case-Control Study at a San Francisco STD Clinic.
Johnson KA; Hessol NA; Kohn R; Nguyen TQ; Mara ES; Hsu L; Scheer S; Cohen SE
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):159-165. PubMed ID: 31192823
[TBL] [Abstract][Full Text] [Related]
17. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study.
Hanum N; Cambiano V; Sewell J; Phillips AN; Rodger AJ; Speakman A; Nwokolo N; Asboe D; Gilson R; Clarke A; Miltz AR; Collins S; Lampe FC;
Lancet Public Health; 2020 Sep; 5(9):e501-e511. PubMed ID: 32888443
[TBL] [Abstract][Full Text] [Related]
18. A Pharmacist-Led, Same-Day, HIV Pre-Exposure Prophylaxis Initiation Program to Increase PrEP Uptake and Decrease Time to PrEP Initiation.
Khosropour CM; Backus KV; Means AR; Beauchamps L; Johnson K; Golden MR; Mena L
AIDS Patient Care STDS; 2020 Jan; 34(1):1-6. PubMed ID: 31944854
[TBL] [Abstract][Full Text] [Related]
19. Integrating and Disseminating Pre-Exposure Prophylaxis (PrEP) Screening and Dispensing for Black Men Who Have Sex With Men in Atlanta, Georgia: Protocol for Community Pharmacies.
Crawford ND; Harrington KRV; Alohan DI; Sullivan PS; Holland DP; Klepser DG; Quamina A; Siegler AJ; Young HN
JMIR Res Protoc; 2022 Feb; 11(2):e35590. PubMed ID: 35138252
[TBL] [Abstract][Full Text] [Related]
20. Examining pharmacies' ability to increase pre-exposure prophylaxis access for black men who have sex with men in the United States.
Alohan DI; Evans G; Sanchez T; Harrington KRV; Quamina A; Young HN; Crawford ND
J Am Pharm Assoc (2003); 2023; 63(2):547-554. PubMed ID: 36470733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
